Phytopharm plc Share Price London S.E.
Equities
GB0006869720
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
23/05 | Ixico wins deal; United Oil & Gas settles debt | AN |
23/05 | IXICO plc Signs Contract with Global Alzheimer's Platform Foundation to Support Bio-Hermes 2 Trial | CI |
Sales 2024 * | 5.2M 6.62M 553M | Sales 2025 * | - | Capitalization | 3.38M 4.31M 360M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.55M -213M | Net income 2025 * | - | EV / Sales 2024 * | 0.38 x |
Net cash position 2024 * | 1.4M 1.78M 149M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.17% |
Latest transcript on Phytopharm plc
Managers | Title | Age | Since |
---|---|---|---|
Giulio Cerroni
CEO | Chief Executive Officer | 63 | 06/17/06 |
Director of Finance/CFO | 47 | 31/19/31 | |
Charles Spicer
CHM | Chairman | 59 | 14/13/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 14/13/14 |
Director/Board Member | 49 | 16/16/16 | |
Dipti Amin
BRD | Director/Board Member | 60 | 05/23/05 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |